Nicholas Naclerio insider trades: Alamar Biosciences (ALMR) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Nicholas reports to the SEC
Open-market buys and sales
34 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Apr 20, 2026 | ALMR | ↑ Buy | 235,294 | $17.00 | $4.0M | Indirect | Apr 20, 2026 (0d) |
| Mar 21, 2016 | ILMN | ↓ Sell10b5-1 | 4,520 | $154.25 | $697K | Direct | Mar 22, 2016 (1d) |
| Jul 15, 2015 | ILMN | ↓ Sell10b5-1 | 6,591 | $229.43 | $1.5M | Direct | Jul 17, 2015 (2d) |
| Jun 15, 2015 | ILMN | ↓ Sell10b5-1 | 6,590 | $214.33 | $1.4M | Direct | Jun 15, 2015 (0d) |
| May 15, 2015 | ILMN | ↓ Sell10b5-1 | 6,590 | $199.16 | $1.3M | Direct | May 19, 2015 (4d) |
| Apr 15, 2015 | ILMN | ↓ Sell10b5-1 | 6,590 | $189.05 | $1.2M | Direct | Apr 16, 2015 (1d) |
| Mar 16, 2015 | ILMN | ↓ Sell10b5-1 | 6,590 | $193.94 | $1.3M | Direct | Mar 18, 2015 (2d) |
| Feb 2, 2015 | ILMN | ↓ Sell10b5-1 | 15,250 | $194.37 | $3.0M | Direct | Feb 2, 2015 (0d) |
| Oct 15, 2014 | ILMN | ↓ Sell10b5-1 | 2,000 | $147.85 | $296K | Direct | Oct 16, 2014 (1d) |
| Sep 15, 2014 | ILMN | ↓ Sell10b5-1 | 2,000 | $169.53 | $339K | Direct | Sep 16, 2014 (1d) |
| Aug 15, 2014 | ILMN | ↓ Sell10b5-1 | 2,000 | $167.23 | $334K | Direct | Aug 18, 2014 (3d) |
| Jul 15, 2014 | ILMN | ↓ Sell10b5-1 | 2,000 | $174.26 | $349K | Direct | Jul 16, 2014 (1d) |
| Jul 1, 2014 | ILMN | ↓ Sell10b5-1 | 25,000 | $181.42 | $4.5M | Direct | Jul 1, 2014 (0d) |
| Jun 16, 2014 | ILMN | ↓ Sell10b5-1 | 2,000 | $169.80 | $340K | Direct | Jun 17, 2014 (1d) |
| Jun 2, 2014 | ILMN | ↓ Sell10b5-1 | 60,000 | $157.60 | $9.5M | Direct | Jun 3, 2014 (1d) |
| May 15, 2014 | ILMN | ↓ Sell10b5-1 | 2,000 | $141.72 | $283K | Direct | May 15, 2014 (0d) |
| Apr 15, 2014 | ILMN | ↓ Sell10b5-1 | 2,000 | $133.56 | $267K | Direct | Apr 16, 2014 (1d) |
| Mar 17, 2014 | ILMN | ↓ Sell10b5-1 | 2,000 | $163.65 | $327K | Direct | Mar 18, 2014 (1d) |
| Feb 18, 2014 | ILMN | ↓ Sell10b5-1 | 2,000 | $169.77 | $340K | Direct | Feb 19, 2014 (1d) |
| Jan 15, 2014 | ILMN | ↓ Sell10b5-1 | 2,000 | $122.27 | $245K | Direct | Jan 17, 2014 (2d) |
| Dec 16, 2013 | ILMN | ↓ Sell10b5-1 | 2,000 | $102.76 | $206K | Direct | Dec 18, 2013 (2d) |
| Nov 15, 2013 | ILMN | ↓ Sell10b5-1 | 2,000 | $93.21 | $186K | Direct | Nov 19, 2013 (4d) |
| Oct 22, 2013 | ILMN | ↓ Sell10b5-1 | 20,000 | $90.00 | $1.8M | Direct | Oct 24, 2013 (2d) |
| Oct 15, 2013 | ILMN | ↓ Sell10b5-1 | 4,000 | $81.32 | $325K | Direct | Oct 17, 2013 (2d) |
| Sep 16, 2013 | ILMN | ↓ Sell10b5-1 | 4,000 | $85.00 | $340K | Direct | Sep 18, 2013 (2d) |
| Sep 3, 2013 | ILMN | ↓ Sell10b5-1 | 59,000 | $76.91 | $4.5M | Direct | Sep 5, 2013 (2d) |
| Aug 15, 2013 | ILMN | ↓ Sell10b5-1 | 2,000 | $78.43 | $157K | Direct | Aug 19, 2013 (4d) |
| Jul 24, 2013 | ILMN | ↓ Sell10b5-1 | 20,000 | $80.00 | $1.6M | Direct | Jul 26, 2013 (2d) |
| Jul 15, 2013 | ILMN | ↓ Sell10b5-1 | 2,000 | $74.50 | $149K | Direct | Jul 17, 2013 (2d) |
| Jun 17, 2013 | ILMN | ↓ Sell10b5-1 | 2,000 | $68.56 | $137K | Direct | Jun 19, 2013 (2d) |
| May 15, 2013 | ILMN | ↓ Sell10b5-1 | 2,000 | $70.72 | $141K | Direct | May 17, 2013 (2d) |
| May 10, 2013 | ILMN | ↓ Sell10b5-1 | 25,000 | $73.00 | $1.8M | Direct | May 14, 2013 (4d) |
| Apr 30, 2013 | ILMN | ↓ Sell10b5-1 | 10,000 | $65.00 | $650K | Direct | May 2, 2013 (2d) |
| Apr 23, 2013 | ILMN | ↓ Sell10b5-1 | 2,000 | $60.00 | $120K | Direct | Apr 24, 2013 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other ALMR insiders
Open-market trades in the last 12 months
About Nicholas Naclerio's insider trades
Nicholas Naclerio is an insider at Alamar Biosciences (ALMR). Since Apr 23, 2013, Nicholas has reported 1 open-market purchase worth $4.0M and 33 sales worth $39.7M on SEC Form 4. In the last 12 months: 1 buy ($4.0M).
33 sales (100% of the value sold) were made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so they say little about how the insider sees the stock today.
Their filings also include option exercises (29 filings), shares withheld for taxes (13 filings), grants and awards (6 filings), conversions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ALMR insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.